Green Synthesis of Silver Nanoparticles (AgNPs), Structural Characterization, and their Antibacterial Potential
- PMID: 35592270
- PMCID: PMC9112420
- DOI: 10.1177/15593258221088709
Green Synthesis of Silver Nanoparticles (AgNPs), Structural Characterization, and their Antibacterial Potential
Abstract
Background: In the field of nanotechnology, the metallic nanoparticles are of remarkable interest because of their unique electronic, magnetic, chemical, and mechanical properties.
Purpose: In the present work, silver nanoparticles (AgNPs) were synthesized using bio-reduction method.
Research design: Silver nitrate was used as metallic precursor and the extract of Moringa oleifera leaves with different concentrations was used as reducing as well capping agent. The extract exhibited strong potential in rapid reduction of silver ions for the synthesis of silver nanoparticles. The synthesized silver nanoparticles were characterized by UV-visible spectroscopy, X-ray diffraction (XRD), and scanning electron microscopy (SEM) techniques.
Results: The absorption SPR peaks appeared in the range of 415 to 439 nm. SEM analysis exhibited that particles were spherical in shape with size distribution range from 10 nm to 25 nm. The synthesized silver nanoparticles were pure crystalline in nature as confirmed by the XRD spectra with average crystallite size 7 nm. In vitro antibacterial activity of the prepared silver nanoparticles colloidal samples as well the extract was studied using different concentrations of AgNPs (C1 = 100 μg/ml, C2 = 50 μg/ml, C3 = 25 μg/ml) by well diffusion method against Gram negative Escherichia coli. The antibacterial performance was assessed by measuring the zone of inhibition (ZOI).
Conclusions: The results suggested that AgNPs prepared by green approach can be considered as an alternative antibacterial agent.
Keywords: AgNPs; Escherichia coli; Moringa oleifera; antibacterial agent; green synthesis.
© The Author(s) 2022.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Whitesides GM. Nanoscience, nanotechnology, and chemistry. Small. 2005;1(2):172-179. - PubMed
-
- Filipponi L, Sutherland D. Interdisciplinary Nanoscience Center (iNANO). Denmark: Aarhus University; 2010.
-
- Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76-83. - PubMed
-
- Ahmad Z, Pandey R, Sharma S, Khuller GK. Alginate nanoparticles as antituberculosis drug carriers: Formulation development, pharmacokinetics and therapeutic potential. Indian J Chest Dis Allied Sci. 2006;48(3):171-176. - PubMed
-
- Gu H, Ho PL, Tong E, Wang L, Xu B. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Letters. 2003;3(9):1261-1263.
LinkOut - more resources
Full Text Sources
Miscellaneous
